Kairos Pharma, Ltd. (KAPA) News

Latest headlines that mention KAPA, newest first · each headline opens the original publisher

KAPA quote

Last price: $0.56
Day change: +2.67%
Next earnings: 2026-11-13

Quote & chart Expected move Insider trading IV rank history

KAPA headlines

latest coverage

Not much coverage yet. KAPA has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 4d ago

Kairos Pharma at LD Micro Main Event: antibody bets on resistance

General T3KAPA

Investing.com 10d ago

Kairos Power raises $643 million for Tennessee reactor - Bloomberg

General T3KAPA

Seeking Alpha 2mo ago

Kairos Pharma announces 1-for-7 reverse stock split to maintain NYSE compliance

General T2KAPA

Investing.com 2mo ago

Kairos Pharma to conduct 1-for-7 reverse stock split

General T3KAPA

Investing.com 4mo ago

Kairos Pharma signs term sheet to acquire lung cancer asset

General T3KAPA

Cointelegraph 5mo ago

Spot HYPE ETFs absorb 1% of market cap in first 10 trading days: Kairos

Spot HYPE ETFs absorbed 1.04% of Hyperliquid’s market cap in 10 trading days, beating Bitcoin and Ether ETF debuts.

Crypto T3KAPA

Investing.com 5mo ago

Form DEF 14A Kairos Pharma Ltd. For: 22 May

General T3KAPA

KAPA news alerts

Get an alert by email or push when a new headline mentions KAPA.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.